↓ Skip to main content

Cochrane Database of Systematic Reviews

Hyperbaric oxygen therapy for multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, January 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
16 tweeters
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
78 Mendeley
Title
Hyperbaric oxygen therapy for multiple sclerosis
Published in
Cochrane database of systematic reviews, January 2004
DOI 10.1002/14651858.cd003057.pub2
Pubmed ID
Authors

Michael H Bennett, Robert Heard

Abstract

Multiple Sclerosis (MS) is a chronic, recurrent and progressive illness with no cure. On the basis of speculative pathophysiology, it has been suggested that Hyperbaric Oxygen Therapy (HBOT) may slow or reverse the progress of the disease.

Twitter Demographics

The data shown below were collected from the profiles of 16 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Unknown 77 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 21%
Student > Bachelor 11 14%
Student > Ph. D. Student 10 13%
Researcher 8 10%
Student > Postgraduate 4 5%
Other 10 13%
Unknown 19 24%
Readers by discipline Count As %
Medicine and Dentistry 24 31%
Nursing and Health Professions 6 8%
Biochemistry, Genetics and Molecular Biology 4 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Psychology 4 5%
Other 16 21%
Unknown 20 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 September 2021.
All research outputs
#1,594,477
of 18,873,384 outputs
Outputs from Cochrane database of systematic reviews
#3,871
of 11,881 outputs
Outputs of similar age
#10,356
of 134,467 outputs
Outputs of similar age from Cochrane database of systematic reviews
#21
of 114 outputs
Altmetric has tracked 18,873,384 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,881 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.6. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 134,467 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 114 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.